The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansDecorin: A Growth Factor Antagonist for Tumor Growth InhibitionDecoding the Matrix: Instructive Roles of Proteoglycan ReceptorsInsights into the key roles of proteoglycans in breast cancer biology and translational medicineSUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.Identifying DCN and HSPD1 as Potential Biomarkers in Colon Cancer Using 2D-LC-MS/MS Combined with iTRAQ Technology.Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone MetastasesDecorin as a multivalent therapeutic agent against cancer.Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers.Matricellular proteins as regulators of cancer metastasis to bone.Characterization of adenoviral transduction profile in prostate cancer cells and normal prostate tissue.Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.Translational aspects in targeting the stromal tumour microenvironment: from bench to bedside.Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.Decorin gene upregulation mediated by an adeno-associated virus vector increases intratumoral uptake of nab-paclitaxel in neuroblastoma via inhibition of stabilin-1.Decorin protects human hepatoma HepG2 cells against oxygen-glucose deprivation via modulating autophagy.Decorin-evoked paternally expressed gene 3 (PEG3) is an upstream regulator of the transcription factor EB (TFEB) in endothelial cell autophagy.Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-β signaling.Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.Decline in Arylsulfatase B Expression Increases EGFR Expression by Inhibiting the Protein Tyrosine Phosphatase SHP2 and Activating JNK in Prostate Cells.
P2860
Q21710680-F59EA87D-A8C8-4F8E-9C9B-AD24A1B6FC28Q26772197-1114E9EC-BC98-4195-8F82-C5277AAACB6CQ26801397-270B3C16-4EA4-42C7-B732-909A5BACC65DQ28085548-EAB2F593-4ECD-4050-A1CC-A60669DE8C43Q33624675-569F6836-8988-4F35-9C51-6006E2808EF3Q36297724-46BD3D5C-9992-498C-AC1F-9089173C85C3Q36406892-023929EE-223F-4D4B-BF03-D7CE60FB7185Q36578803-2505D189-24D8-4E5F-AA72-C5C699F5E547Q36594178-EB54A074-3469-4FEE-9D9A-C79FED416E8BQ36923653-235A747C-8A9B-4A0B-9A25-7CCAC5C4D2BDQ38654668-235DEE51-9649-4C64-BE70-2DF4DD5F9061Q38744936-DAE3C0D5-D170-4558-A0A5-DE89078E3902Q38858806-74910989-FFB7-4B4B-A3FF-73F431DDE64EQ39012517-51C12CA2-B142-4AC7-86F0-A17A0D4105A5Q40153387-D8DCB78B-8D3C-4857-A0A8-22D1E97BFB20Q41877180-FB1A7235-F9FD-4C4D-9C0A-C1EC11134126Q42095044-8C1439A4-3C9E-441D-9777-EADB5D9DDCB8Q42433114-97F37EB1-DC88-4AD6-8A0D-0329873C245FQ50052813-BA0A4153-F024-4D33-85FA-DD44549A4AA6Q54978374-E36484EF-5847-4510-BEC9-241BBAEF8717
P2860
The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The systemic delivery of an on ...... odel of human prostate cancer.
@ast
The systemic delivery of an on ...... odel of human prostate cancer.
@en
type
label
The systemic delivery of an on ...... odel of human prostate cancer.
@ast
The systemic delivery of an on ...... odel of human prostate cancer.
@en
prefLabel
The systemic delivery of an on ...... odel of human prostate cancer.
@ast
The systemic delivery of an on ...... odel of human prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
The systemic delivery of an on ...... model of human prostate cancer
@en
P2093
C Brendler
E Cleveland
P2860
P2888
P304
P356
10.1038/GT.2014.110
P577
2014-12-11T00:00:00Z